首页> 外文期刊>Microbial Cell Factories >Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy
【24h】

Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy

机译:三维肿瘤球体,用于体外分析细菌作为肿瘤治疗中的基因传递载体

获取原文
       

摘要

Several studies in animal models demonstrated that obligate and facultative anaerobic bacteria of the genera Bifidobacterium, Salmonella, or Clostridium specifically colonize solid tumors. Consequently, these and other bacteria are discussed as live vectors to deliver therapeutic genes to inhibit tumor growth. Therapeutic approaches for cancer treatment using anaerobic bacteria have been investigated in different mouse models. In the present study, solid three-dimensional (3D) multicellular tumor spheroids (MCTS) of the colorectal adenocarcinoma cell line HT-29 were generated and tested for their potential to study prodrug-converting enzyme therapies using bacterial vectors in vitro. HT-29 MCTS resembled solid tumors displaying all relevant features with an outer zone of proliferating cells and hypoxic and apoptotic regions in the core. Upon incubation with HT-29 MCTS, Bifidobacterium bifidum S17 and Salmonella typhimurium YB1 selectively localized, survived and replicated in hypoxic areas inside MCTS. Furthermore, spores of the obligate anaerobe Clostridium sporogenes germinated in these hypoxic areas. To further evaluate the potential of MCTS to investigate therapeutic approaches using bacteria as gene delivery vectors, recombinant bifidobacteria expressing prodrug-converting enzymes were used. Expression of a secreted cytosine deaminase in combination with 5-fluorocytosine had no effect on growth of MCTS due to an intrinsic resistance of HT-29 cells to 5-fluorouracil, i.e. the converted drug. However, a combination of the prodrug CB1954 and a strain expressing a secreted chromate reductase effectively inhibited MCTS growth. Collectively, the presented results indicate that MCTS are a suitable and reliable model to investigate live bacteria as gene delivery vectors for cancer therapy in vitro.
机译:在动物模型中的数项研究表明,双歧杆菌,沙门氏菌或梭状芽胞杆菌属的专性兼性厌氧菌可在结肠肿瘤中特异地定殖。因此,将这些细菌和其他细菌作为活载体进行讨论,以传递治疗性基因来抑制肿瘤的生长。已经在不同的小鼠模型中研究了使用厌氧细菌治疗癌症的治疗方法。在本研究中,结直肠腺癌细胞系HT-29的立体三维(3D)多细胞肿瘤球体(MCTS)生成并测试了其在体外使用细菌载体研究前药转化酶疗法的潜力。 HT-29 MCTS类似于实体瘤,显示所有相关特征,其核心是增殖细胞的外部区域以及缺氧和凋亡区域。与HT-29 MCTS孵育后,双歧双歧杆菌S17和鼠伤寒沙门氏菌YB1选择性定位,存活并在MCTS内的低氧区域复制。此外,专性厌氧产气荚膜梭状芽孢杆菌的孢子在这些低氧区域发芽。为了进一步评估MCTS研究使用细菌作为基因传递载体的治疗方法的潜力,使用了表达前药转化酶的重组双歧杆菌。分泌的胞嘧啶脱氨酶与5-氟胞嘧啶合用的表达对MCTS的生长没有影响,这是因为HT-29细胞对5-氟尿嘧啶即转化的药物具有内在抗性。但是,前药CB1954和表达分泌型铬酸盐还原酶的菌株的组合可有效抑制MCTS的生长。总体而言,目前的结果表明,MCTS是研究活细菌作为体外癌症治疗的基因传递载体的合适且可靠的模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号